Changes in the Functional Capacity of Marrow Stromal Cells after Autologous Bone Marrow Transplantation
Authors:
- 1 January 1998
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 29 (5-6) , 533-546
Abstract
Marrow stromal cells were evaluated several months after autologous BMT for their capacity to support both normal hemopoiesis and secrete the main growth factors involved in its control, G-CSF, GM-CSF, IL-3 and SCF. Stromal layers (SL) were obtained by long-term marrow cultures (LTMC) established from 15 patients (9 with hematologic malignancies and 6 with solid tumors) 3 months after autologous BMT and were compared to pre-graft patients. After irradiation, both post-graft and pre-graft SL were recharged with the same inoculum of normal marrow cells. As compared to pre-graft values, CFU-GM production on post-graft SL was significantly increased during the first 2 weeks of culture whereas it was decreased from week 3 to week 8. These findings were only observed in patients with hematologic malignancies and not in patients with solid tumors. Growth factor secretion was evaluated by ELISA in the supernatants of unstimulated and IL-1 -stimulated SL from 10 post-graft patients, 13 pre-graft patients and 5 normal controls. In any group of patients, IL-3 was undetectable either spontaneously or after IL-1-stimulation. As compared to controls, secretion by IL-1 -stimulated SL was not different for GM-CSF in pre-and post-graft patients but tended to be decreased for G-CSF in post-graft patients. SCF secretion, which was not induced by IL-1, appeared dramatically decreased in both pre-and post-graft patients. The capacity of post-graft SL to support CFU-GM growth in LTMC was correlated at week 1 with G-CSF secretion and from week 3 to week 8 with SCF secretion. These results suggest that microenvironment remains qualitatively damaged several months after BMT involving a decreased capacity both to support early hemopoiesis and to secrete SCF, particularly in patients grafted for hemopoietic malignancies.Keywords
This publication has 26 references indexed in Scilit:
- Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy [see comments]Blood, 1994
- Interleukin 1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony- stimulating factorBlood, 1988
- Clonogenic hemopoietic precursors in bone marrow transplantationBlood, 1987
- Different repopulation kinetics of erythroid (BFU-E), myeloid (CFU-GM) and T lymphocyte (TL-CFU) progenitor cells after autologous and allogeneic bone marrow transplantationBritish Journal of Haematology, 1987
- Haemopoietic reconstitution after allogeneic bone marrow transplantation in man: recovery of haemopoietic progenitors (CFU‐Mix, BFU‐E and CFU‐GM)British Journal of Haematology, 1987
- Autologous bone marrow transplantation for acute leukaemia in remissionBritish Journal of Haematology, 1986
- Abnormalities of myeloid progenitor cells after "successful" bone marrow transplantation.Journal of Clinical Investigation, 1985
- The use and potential of bone marrow allograft and whole-body irradiation in the treatment of leukemiaCancer, 1982
- Cure of Hematologic Neoplasia with Transplantation of Marrow from Identical TwinsNew England Journal of Medicine, 1977
- Conditions controlling the proliferation of haemopoietic stem cells in vitroJournal of Cellular Physiology, 1977